the aid library

LIST OPTIONS

Filter

6118

External Link

Une meilleure gestion des déchets d’activités de soins

Rushbrook, R.; Zghondi, R. OMS; Banque Mondiale (2005) C_WHO

Une composante intégrale de l’investissement dans la santé

Download (1719)

View PDF (3462)

Tool for the assessment of injection safety

World Health Organization (2001) C_WHO

Download (1022)

View PDF (1940)

Aide-mémoire for a strategy to protect health workers from infection with bloodborne viruses

World Health Organization (2003)

Download (333)

View PDF (318)

COVID-19 Vaccine Operational Guidelines

Ministry of Health and Family Welfare, Government of India (2020) C1

Updated 28 December 2020

Download (514)

View PDF (626)

Lao People’s Democratic Republic-WHO Country Cooperation Strategy 2024–2028

World Health Organization WHO (2023) C_WHO

This country cooperation strategy (CCS) outlines how the World Health Organization (WHO) will work with the Lao People’s Democratic Republic over the next five years (2024–2028), supporting the implementation of the five-year health sector development plans and the Health Sector Reform Strategy ...2021–2030 to attain the Sustainable Development Goals (SDGs) by 2030. The Lao People’s Democratic Republic experienced substantial economic growth in the 30 years prior to the coronavirus disease (COVID-19) pandemic, contributing to reduced poverty and significant progress toward the SDGs. However, the COVID-19 pandemic brought this development to a halt. It was anticipated that the COVID-19 recovery and the tremendous population growth in recent years would provide opportunities for a shift toward more sustainable and inclusive development in the years ahead. In 2023, however, the contrary was the case. Rural residents, including many ethnic minorities, continued to face marginalization because of limited access to education, health care and economic opportunities. Despite the challenges of COVID-19 and other disease outbreaks, the country has made significant improvements in health. Nonetheless, progress has been uneven and not everyone has benefited from these achievements. In the mountainous region, many people lack access to quality health care because of the unequal distribution of well-trained health-care workers. Preventable deaths due to poor-quality health care for children and newborns, infants and mothers remain a concern, as do communicable diseases such as sexually transmitted infections and tuberculosis. The increasing burden of noncommunicable diseases and the health impact of worsening climate change further heighten the need for strengthened and resilient health systems, which are at risk due to an underfunded health sector and weak economy. This CCS aims to address remaining and future challenges as well as health needs while creating an impact that is sustainable. It identifies three strategic priorities and nine deliverables (Table 1) to support the attainment of the national vision of Health for all by all, as articulated in the 9th Health Sector Development Plan 2021–2025. It contributes to the country’s goals to achieve universal health coverage, graduate from least developed country status by 2026 and attain SDGs by 2030. more

Download (504)

View PDF (565)

Limpieza y desinfección de las superficies del entorno inmediato en el marco de la COVID-19
recommended

Organización Mundial de la Salud OMS (2020) C_WHO

El propósito de este documento es proporcionar orientación sobre la limpieza y desinfección de las superficies ambientales en el contexto de COVID-19. Esta orientación está destinada a los profesionales de la salud, los profesionales de la salud pública y las autoridades sanitarias que están ... more

Download (537)

View PDF (459)

International health regulations (‎2005)‎: state party self-assessment annual reporting tool, 2nd ed

World Health Organization WHO (2022) C_WHO

Second edition. AVailable in English, French, Spanish, Russian, Chinese and Portuguese

Download (471)

View PDF (619)

Fit for women? Safe and decent PPE for women health and care workers

Women for Global Health WGH (2021) CC

One of the many gender inequities in the health and care workforce that COVID-19 has exposed is around the fit and design of Personal Protective Equipment (PPE). The rapid onset and scale of COVID-19 led to shortages of PPE in most countries, causing preventable infection and mortality among healthc... more

Download (1168)

View PDF (1735)

Global report on psoriasis

World Health Organization WHO (2016) C_WHO

Psoriasis, which can involve the skin, nails and joints, is a chronic, painful, disfiguring and disabling noncommunicable disease (NCD) for which there is no cure. It negatively impacts on quality of life. Some of those who suffer from the disease develop chronic, inflammatory arthritis (psoriatic a... more

External Link

Cervical Cancer Control in India
recommended

ecancer Education; National Cancer Crid, India (2019) CC

A new e-learning course has just been released, aimed at healthcare professionals working with patients in India exploring HPV screening and vaccination, assessment and diagnosis of cervical cancer, and palliative care for patients with advanced cervical cancer. The course was developed by ecancer i... more

Download (572)

View PDF (770)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (410)

View PDF (650)

Cleaning and disinfection of environmental surfaces in the context of COVID-19
recommended

World Health Organisation (2020) C_WHO

The purpose of this document is to provide guidance on the cleaning and disinfection of environmental surfaces in the context of COVID-19. This guidance is intended for health care professionals, public health professionals and health authorities that are developing and implementing policies and sta... more

Download (1635)

View PDF (3295)

Bambo has bilharzia: what children should know about bilharzia
recommended

World Health Organization WHO (2013) C_WHO

Educational Comic book

Download (1251)

View PDF (2222)

Measles Elimination Field Guide

World Health Organization, Western Pacific Region (2013) C_WHO

External Link

Neonatal vitamin A supplementation

World Health Organization WHO (2011)

Download (290)

View PDF (443)

Managing Common Coinfections and Comorbidities

World Health Organization WHO (2013) C_WHO

Clinical Guidance across the continuum of care Chapter 8_ARV Guidelines

Download (606)

View PDF (977)

Tuberculosis laboratory biosafety manual

World Health Organization (2012) C_WHO

Download (598)

View PDF (1083)

INSPIRE: Seven strategies for Ending Violence Against Children

Alexander Butchart, Susan Hillis, Angela Burton et al. World Health Organisation (WHO) (2016) C_WHO

Download (314)

View PDF (462)

Community management of opioid overdose

World Health Organization (2014) C_WHO

Download (695)

View PDF (1090)

Validation of elimination of trachoma as a public health problem

World Health Organization WHO (2016) C_WHO

These standard operating procedures are intended to be used when a Member State wishes to request validation of national elimination of trachoma as a public health problem following implementation of the SAFE strategy,1 which comprises: surgery for trachomatous trichiasis, antibiotics to clear infec... more

Limpieza y desinfección de las superficies del entorno inmediato en el marco de la COVID-19 recommended

Cervical Cancer Control in India recommended

Cleaning and disinfection of environmental surfaces in the context of COVID-19 recommended

Bambo has bilharzia: what children should know about bilharzia recommended

Limpieza y desinfección de las superficies del entorno inmediato en el marco de la COVID-19
recommended

Cervical Cancer Control in India
recommended

Cleaning and disinfection of environmental surfaces in the context of COVID-19
recommended

Bambo has bilharzia: what children should know about bilharzia
recommended